The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.
FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]
Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.
The State University of New York (SUNY) is running the program with $20 million funding from the Empire State Development’s […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.
Huge viruses with CRISPR-Cas and translational components have been described by researchers at the University of California, Berkeley – providing […]
Professor Ernst Hafen is based at the Institute of Molecular Systems Biology at ETH Zurich. He studied the developmental and […]
We know from twin studies that Schizophrenia carries a 80% heritability risk, but haven’t yet managed to deduce exact genetic […]